INTRODUCTION
Cardiolipin (CL), the first polyglycerophospholipid discovered, was isolated from bovine heart by Mary Pangborn in 1942 [1] . In mammalian tissues, CL is characteristically associated with the mitochondrial inner membrane [2] and is required for the activity of, or intimately associated with, a number of key mitochondrial enzymes, including cytochrome c oxidase [3] . In rat heart CL is a major phospholipid component comprising approx. 15 % of the entire cardiac phospholipid mass [4] .
The pathway for biosynthesis of CL was first elucidated by Kennedy and co-workers for Escherichia coli [5, 6] . Regulation of the enzymes and the mechanisms which govern CL biosynthesis in bacteria [7, 8] and in yeast [9, 10] are well documented. In mammalian tissues biosynthesis of CL occurs via CDP-sn-1,2-diacylglycerol (CDP-DG), catalysed by CTP:phosphatidic acid (PA) cytidylyltransferase (EC 2.7.7.41) [11] . This reaction occurs in both mitochondrial and microsomal fractions [12] . It is not known if newly synthesized or pre-existing PA is used for CL biosynthesis in mammalian heart. The committed step of CL biosynthesis involves the conversion of CDP-DG into phosphatidylglycerol (PG) by sequential action of phosphatidylglycerol phosphate (PGP) synthase (EC 2.7.8.5) and PGP phosphatase (EC 3. 1.3.27) . PGP synthase has been partially purified from mammalian liver mitochondria [13] . None of the above enzymes has been purified to homogeneity from any mammalian source. In the final step of the pathway, PG is then converted into CL via condensation with CDP-DG catalysed by CL synthase. CL synthase was recently purified to homogeneity from rat liver mitochondria by Schlame and Hostetler [14] . The ing step of cardiolipin biosynthesis, hearts were pulsed for 5 min with 0.1 ,uM [1,(3) -3H]glycerol and chased for up to 60 min with 0.1 utM glycerol in the perfusate. Radioactivity was maximum at the start of the chase in phosphatidic acid (and 1,2-diacylglycerol), and was subsequently chased into phosphatidylinositol, phosphatidylglycerol and cardiolipin (and other phospholipids). Significant radioactivity in phosphatidylglycerol phosphate was not detected. Radioactivity in CDP-sn-1 ,2-diacylglycerol remained constant throughout the chase. The activities of the enzymes of the Kennedy pathway for cardiolipin biosynthesis in the heart were determined. On the basis of continuous-pulse and pulse-chase labelling studies it is postulated that the cardiac polyglycerophospholipids phosphatidylglycerol and cardiolipin are actively synthesized from newly synthesized phosphatidic acid via the Kennedy pathway. In addition, the results suggest that the rate-limiting step of cardiolipin biosynthesis in the intact heart is probably the conversion of phosphatidic acid into CDP-sn-1,2-diacylglycerol.
enzyme is localized to the mitochondrial inner membrane [15] . The rate-limiting step of this pathway for CL biosynthesis in mammalian heart is unknown.
Although CL plays an important role in the maintenance of mitochondrial function and membrane integrity, studies on the biosynthesis of this important phospholipid in intact organs have been largely ignored. Most studies on polyglycerol phospholipids and their biosynthesis in mammalian tissues have been performed in tissue subcellular fractions [11, 16] . There are no detailed studies on CL biosynthesis in the isolated intact rat heart. In fact, a previous study demonstrated that isolated rat heart mitochondrial fractions did not have the ability to synthesize CL from radioactive sn-glycerol 3-phosphate (GP) [17] . It could be argued that the biosynthesis of CL in the mammalian heart should be similar to that of the liver, lung and brain subcellular fractions. However, the liver and lung actively secrete phospholipids in the form of lipoproteins (liver) and surfactant (lung) and have much lower concentration (> 2.6-fold and > 19-fold, respectively) of CL [4] . In addition, the brain content of CL is > 45-fold lower than that ofheart [18] . Thus their phospholipid and CL biosynthesis might be different from that in an organ which has a greater content of CL and does not secrete phospholipid. The objective of the present study was to investigate CL biosynthesis in the intact heart. In this study, the pathway for new CL biosynthesis in the isolated perfused intact rat heart is identified. In addition, we demonstrate that newly synthesized PA is used for CL biosynthesis and that the rate-limiting step of CL biosynthesis is likely to be the conversion of PA into CDP-DG in the isolated perfused heart.
Abbreviations used: CL, cardiolipin; PG, phosphatidylglycerol; PA, phosphatidic acid; PGP, phosphatidylglycerol phosphate; KHB, Krebs Preparation of rat heart mitochondrial fractions Animals were killed by decapitation, and the heart was rapidly removed and cannulated via the aorta and 10-20 ml of ice-cold 0.145 M NaCl was perfused through the heat to remove blood. Subsequent steps were performed exactly as described previously [20] . Enzyme activity was linear with time up to at least 10 min with 0.1 mg of protein.
PGP synthase was assayed by a modification of the method of Carman and Belunis [21] . The incubation mixture contained enzyme (50-100 tg) and 0.145 M NaCl added to a volume of 50,al, 10 l,l of 0.5 M Tris/HCl, pH 7.0, 10 lul of fl-mercaptoethanol (prepared fresh) and 10 1 of 5.0 mM [U-14C]GP (sp. radioactivity 12500 d.p.m./nmol). The reaction was initiated by addition of 10 ,dl of lOO mM MgCl2,6H20. The mixture was incubated at 30°C for 10 min and terminated by addition of 0.5 ml of 0.1 M HCI in methanol, and subsequent steps were performed exactly as described previously [21] . Enzyme activity was linear with time up to at least 15 min with 0.1 mg of protein.
PGP phosphatase activity was assayed by a modification of the method of Macdonald and McMurray [13] . The incubation mixture contained 10 ,ul of 0.5 M Tris/maleate, pH 6.5, 10 ,1 of 0.1 M ,-mercaptoethanol, 10 ,ul of 40 Perfusion of isolated rat hearts in the Langendorff mode with radioactive glycerol and P, The animal was killed by decapitation and the heart quickly removed, cleaned of extraneous tissue, and cannulated via the aorta. Then 5 ml of Krebs-Henseleit buffer (KHB) [23] was perfused through the heart with a syringe to remove blood, and the heart was subsequently placed on the perfusion apparatus and perfused in the Langendorffmode [24] with KHB (5 ml/min) saturated with 02/CO2 (19: 1) at 37°C for 5 min or until electrical stabilization was achieved. An electrode was placed on the aorta and another electrode immersed in the buffer solution bathing the apex of the heart, and the viability of the heart was monitored by electrocardiac recording. This procedure allows assessment of both ventricular and atrial activities simultaneously. The pO2 of the buffer was 69.6 + 2.0 kPa. Under these conditions the heart remained electrically stable, and therefore viable, for up to 4 h of perfusion [25] . In continuous-pulse experiments, after stabilization, the hearts were perfused with 12 (5 ,uCi/ml) for 5 min and subsequently perfused with 12.5 ml of KHB containing 0.1 ,uM glycerol for up to 60 min. After perfusion, 10 ml of air was forced through the heart to remove the residual perfusate in the vessels. The heart was cut open, blotted dry, and the wet weight determined. The homogenization, extraction and t.l.c. were performed within 48 h, and radioactivity incorporated into phospholipids was determined immediately thereafter.
Isolation and analysis of radioactive phospholipids
The heart (typically 0.40-0.45 g) was perfused as described above, and after perfusion the heart was homogenized (20 s burst of Polytron homogenizer) in 5 ml of chloroform/methanol (2:1, v/v) containing butylated hydroxytoluene (0.05 mg/ml). Tissue left on the generator probe was removed and homogenized in another 5 ml of the chloroform/methanol. The homogenates were combined and centrifuged at 1000 g for 20 min in a benchtop centrifuge to pellet debris. A 100 ,ul sample ofthe homogenate was taken (with a Hamilton syringe) for the determination of total radioactive glycerol associated with the heart. The homogenate was transferred to 16 mm x 125 mm screw-cap tubes, and 5 ml of 0.73 % NaCl was added to the homogenate to initiate phase separation. The tubes were shaken for 5 min and then centrifuged at 1000 g (model TJ-6 bench-top centrifuge) for upper phase (chloroform/methanol/0.9 % NaCl, 3:48:47, by vol.) was added to wash the organic phase. The tubes were mixed and centrifuged as described above, and the aqueous phase was removed and combined with that of the first centrifugation. The organic phase was dried under a stream ofN2 gas and resuspended in 100 ,1 of chloroform/methanol (2: 1, v/v). A 10 ,ul sample was taken for determination of radioactivity associated with the organic phase. A 20 ,1 portion of the organic phase was placed on a thin-layer plate and phospholipids were separated by the two-dimensional t.l.c. procedure described [4] . The thin-layer plates were prepared by spraying the plate lightly with 0.4 M boric acid, blotting dry the excess boric acid and then air-drying the plates overnight. PG and PA standards were placed on the plate before chromatography, except when lipid phosphorus analysis was performed. In some experiments, a 10 ,tl portion of the organic phase was placed on a thin-layer plate with a sample of CDP-DG standard and separated from other lipids as described for CDP-DG [26] . In other experiments a 10 ,ul sample was placed on a thin-layer plate with a portion of PGP standard and separated as described [27] . Oxalate-treated plates were used for PGP separation. In the pulse-chase experiments a 10 sample of the organic phase was placed on a thin-layer plate, and DG was separated in a solvent system containing diethyl ether/ benzene/ethanol/acetic acid (225:250:10:1, by vol.). The lipids were revealed with iodine vapour and removed into 7 ml scintillation vials. Then 0.5 ml of water was added and the vials were sonicated for 5 min to disperse the silica gel. Finally, 5 ml of Ecolite scintillation cocktail was added. The radioactivity was determined in a Beckman model LS 3801 scintillation counter with internal standards.
Other procedures
Non-perfused hearts and hearts perfused for 60 min with KHB containing either 0.1 ,uM or 0.1 mM glycerol were analysed for P present in phospholipids. The lipid-extraction procedure was the same as described above. A 35 p.1 sample of the organic phase was placed on the borate-treated thin-layer plates, and phospholipids were separated in the two-dimensional system [4] . The phospholipid spots were removed and the P content of phospholipids were determined by the method of Rouser et al. [28] . Protein concentration was determined by the method of Bradford [29] . Results in this study are depicted as means + S.D.
RESULTS

Enzyme activities in vitro involved in cardiolipin blosynthesis
The activities in vitro of the enzymes involved in CL biosynthesis were investigated in subcellular fractions prepared from rat heart. A 5 % homogenate was prepared in 0.145 M NaCl and subcellular fractions were obtained by differential centrifugation. The activities of these enzymes were assayed under optimal conditions. CTP: PA cytidylyltransferase activity was localized to both crude mitochondrial (Table 1 ) and microsomal fractions. Microsomal PA: CTP cytidylyltransferase activity was 61+9 pmol/min per mg of protein. PGP synthase, PGP phosphatase and CL synthase were localized to the mitochondrial fraction (Table 1) . PGP phosphatase activity has been identified in the soluble fraction of baby-hamster kidney cells [30] . No such extra-mitochondrial activity was found in the heart.
CL blosynthesis from glycerol
Since glycerol is a common precursor for phospholipid 20 min. The aqueous phase was removed and 5 ml of theoretical biosynthesis, the contribution of the Kennedy pathway to CL biosynthesis was evaluated in the isolated rat heart. Hearts were perfused for various times with 0.1 ,uM [U-14C]glycerol (1 ,uCi/ml). Total uptake of radioactive glycerol was 2.4 x 106 d.p.m./g of heart, and was maximal by 15 min of perfusion and remained constant throughout the pulse period up to 60 min of perfusion. In addition, radioactivity associated with the organic phase was 0.35 x 106 d.p.m./g of heart, and was maximum by 15 min of perfusion and remained constant throughout the perfusion. Radioactivity incorporated into CL increased with time of perfusion (Figure la) . In addition, radioactivity incorporated into PG increased with time of perfusion ( Figure I b) . By 15 min of perfusion, the earliest time point examined, radioactivity in PA was maximum and decreased with time of perfusion, consistent with radioactivity being incorporated into PG and CL ( Figure Ib) . Significant radioactivity could not be detected in PGP. This was not surprising, since PGP is not observed in vivo [5] ; however, see [16] . (2 uCi/ml) in the perfusate. This is representative of the circulating plasma concentration of glycerol in the rat [31] . The total radioactivity associated with the hearts was (3.45 +0.31) x IOf d.p.m./g of heart by 15 min of perfusion and remained constant thereafter. This was calculated to be 6.2 % of the radioactivity in the starting perfusate. In addition, the radioactivity associated with the organic phase increased from (3.0+0.4) x 105 to (1.1 +0.1) x 106 d.p.m./g of heart by 60 min of perfusion. In contrast with hearts perfused with 0.1 ,uM glycerol, the radioactivity in PA in these hearts was increased with time of perfusion (Figure 2a) . This was likely to be due to the continuing incorporation of radioactive glycerol into the organic phase. Radioactivity in PG (Figure 2a ) and CL ( Figure  2b) Figure 3 , CL, PG Pool sizes of PA, PG and CL
The pool sizes of CL, PG and PA were determined in nonperfused hearts and in hearts perfused for 60 min with either 0.1 ,uM or 0.1 mM glycerol. Hearts were homogenized in chloroform/methanol as described in the Materials and methods section, and after phase separation the organic phase was dried under N2 gas and resuspended in 100 ,dl of chloroform/methanol (2: 1, v/v) and a 5 ,ul sample was removed for the determination of total lipid P. A 35 ,1 sample of the organic phase was placed on a thin-layer plate, and PA, PG and CL were separated by two-dimensional t.l.c. and the P contents determined. CL (2529 + 217 nmol/g of heart), PG (262 + 42 nmol/g of heart) and PA (48 + 7 nmol/g of heart) represented approx. 15 %, 1.6% and 0.28 % of the total phospholipid mass in these hearts respectively. The results for percentage of total lipid P agree with those reported previously by Poorthuis et al. [4] for PG and CL and by Simon and Rouser [18] for PA. The pool sizes of PA, PG and CL were unaltered after perfusion with 0.1,IM or 0.1 mM glycerol compared with non-perfused hearts (results not shown).
The rate-limiting step of CL biosynthesis In heart A pulse-chase protocol was established to determine the ratelimiting step of CL biosynthesis in the heart. Hearts were perfused for 5 min with 0.1 uM [1,(3)-3H]glycerol (5 ,Ci/ml), and subsequently the radioactivity was chased with 0.1 uM glycerol in the perfusate for up to 60 min. Total radioactivity associated with the hearts was decreased from (8.82+ 1.01) x 106 d.p.m./g of heart at the start of the chase to (4.43 + 0.77) x 106 d.p.m./g of heart by 60 min of chase. The radioactivity lost from the hearts was quantitatively recovered in the perfusate and identified as glycerol. Radioactivity associated with the organic phase was (1.9 + 0.2) x 106 d.p.m./g of heart, was maximum at the beginning of the chase and remained constant throughout the chase. Radioactivity in PA was maximum at the beginning of the chase and decreased with time ( Figure 4a ). This was accompanied by an increase in radioactivity associated with PG and CL with time of chase (Figures 4a and 4b) . Radioactivity in CDP-DG was 
DISCUSSION
The objective of this study was to identify the major pathway for the biosynthesis of new CL in the isolated rat heart. To mimic the conditions of the beating heart in vivo, isolated rat hearts were perfused in the Langendorff mode [24] with KHB [23] containing radioactive glycerol or Pi. This method allowed the simultaneous monitoring of the incorporation of radioactive glycerol or Pi into CL and the electrocardiac activity of the beating heart. Under these conditions, no change in the electrocardiac function of the beating heart up to and including 60 min of perfusion was observed. Thus the viability of the heart was maintained throughout the perfusion experiments.
In mammalian tissues exogenous glycerol has been widely used to study phospholipid biosynthesis [32] [33] [34] . When hearts were perfused for up to 60 min with 0.1 ,uM [U-14C]glycerol in the perfusate, a decreased radioactivity in PA was accompanied by an increase in radioactivity incorporated into CL and other phospholipids. These studies are consistent with an earlier observation by Akesson et al. [34] . In that study rats were injected intraportally with radioactive glycerol, and the livers were removed at various times after injection and the radioactivity incorporated into lipids was determined. The radioactivity in PA was maximum by 20-30 s and declined as radioactivity was incorporated into other phospholipids and triacylglycerols. To confirm the active synthesis of CL, we utilized a different phospholipid precursor, [32P]P . Perfusion of hearts with [32P]Pi revealed that CL could be actively synthesized from Pi as a substrate precursor in the isolated perfused intact rat heart. Since the radioactivity from both [32P]Pi and [14C]glycerol was incorporated rapidly into PA and more slowly into CL, these data clearly demonstrate that the rat heart can actively synthesize CL, and that this synthesis most likely occurs via the Kennedy pathway.
In the continuous pulse-labelling studies with radioactive glycerol, radioactivity in the heart was maximal by 15 min of perfusion with radioactive 0.1 ,uM or 0.1 mM glycerol in the perfusate. These data suggest that the isolated perfused rat heart must have a great capacity to take up glycerol. The circulating plasma concentration of glycerol in the rat is approx. 0.1 mM [31] , and cell membranes are freely permeable to glycerol. Therefore plasma glycerol must rapidly enter the heart during perfusion, and in the present study a rapid equilibrium of radiolabelled glycerol must have occurred within 15 min.
Once inside the cell, glycerol can be converted into GP by glycerol kinase. A previous study had indicated that the rat heart contained no glycerol kinase activity [35] . However, a subsequent study demonstrated the activity to be present in the myocardium [36] . Radioactivity associated with PA rapidly reached a maximum by 15 min of perfusion when 0.1 uM glycerol was present in the perfusion medium. These data indicate that the isolated perfused rat heart can rapidly synthesize PA from this exogenous glycerol source. Evidence in support of this was the studies with [32P]P . In these studies, the relative rate of incorporation of 32P radioactivity into PA was approx. 27-30-fold higher than into lysoPA. This indicates that the lysoPA produced in the heart from radioactive GP must be rapidly converted into PA. In hearts perfused with radioactive glycerol, radioactivity increased with time into PA when 0.1 mM glycerol was present in the perfusate, but was lost out of PA when 0.1 ,uM glycerol was present in the perfusate; yet in the presence of either glycerol concentration, radioactivity was incorporated with time into all other phospholipids. This was likely due to the increased incorporation of radioactive glycerol into the organic phase in the presence of0.1 mM glycerol in the perfusate, whereas glycerol incorporation into the organic phase was maximum by 15 min of perfusion with 0.1 aM glycerol. This was consistent with a previous study in liver slices [37] . In that study, the rate of glycerol incorporation into the lipid fraction was shown to differ with various glycerol concentrations in the incubation medium. The differential labelling of PA, in the presence of the two different glycerol concentrations, compared with other phospholipids is explained by the fact that PA lies at a branch point in glycerolipid synthesis and that both CDP-DG and DG, required for the synthesis of all the major phospholipids, are produced from this key phospholipid [38] . Thus, since radioactivity in the organic phase was maximal by 15 min in the hearts perfused with 0.1 ,uM glycerol, then the time-dependent movement of radioactivity would have be out of PA and into other phospholipids.
On the basis of continuous-pulse-labelling studies with 0.1 ,uM glycerol in the perfusate, the rate-limiting step of PG and CL biosynthesis in the isolated heart appeared to be the conversion of PA into CDP-DG. Since the pool size of PA did not change when hearts were perfused for up to 60 min with 0.1 ,uM glycerol in the perfusate, a pulse-chase protocol was implemented to confirm this hypothesis. In these studies, a decreased radioactivity associated with PA (and DG) was accompanied by an increase in radioactivity incorporated into PI, PG and CL (and other phospholipids). Radioactivity in CDP-DG remained constant throughout the chase. Thus it appeared that some of the radioactive CDP-DG produced was rapidly converted into PI, PG and CL. CTP: PA cytidylyltransferase activity has been demonstrated in both mitochondrial and microsomal fractions of rat liver homogenates [12] . In the liver the activity of the microsomal enzyme exceeded the activity of the mitochondrial enzyme [39] . In the present study, the activities in these two fractions were similar. This might be due to the greater requirement of the heart for CL biosynthesis, since the content of CL is almost 2.6-fold that of the liver, whereas the content of PI, which is synthesized in the endoplasmic reticulum [12] , is almost 3.6-fold higher in the liver than the heart [4] . We did not observe any accumulation of radioactivity in PGP. This was not surprising, since PGP phosphatase activity was almost 12-fold greater than the PGP synthase activity, and thus any PGP produced should be rapidly converted into PG. The small amount of CL synthase activity observed might suggest that this step should be rate-limiting for CL biosynthesis in the heart. Indeed, regulation of rat liver CL synthase activity by thyroid hormone has been documented [40] , and this may be associated with alterations in liver CL mass [41] . The data in the present paper do not refute the possibility that the CL synthase is rate-limiting. However, at least under the conditions of the present study, the rate-limiting step of new CL biosynthesis in the isolated perfused heart is likely to be the conversion of PA into CDP-DG.
Another pathway of CL biosynthesis, via phospholipase D, was postulated [42] . In these experiments, exogenous cabbage phospholipase D and radioactive PG produced CL. The 10000 g fraction of rat ventricular myocardium was shown to contain a small amount of phospholipase D activity towards PC [43] .
However, phospholipase D activity towards PG has not been reported in rat heart mitochondria. Thus this pathway likely contributes little, if at all, to new CL biosynthesis in the heart. A previous study reported that PGP and PG could be synthesized in vitro from radioactive GP in mitochondrial fractions prepared from rat heart [17] . No radioactive CL was detected. In another study, radioactive CL was synthesized in vitro from radioactive GP in guinea-pig heart mitochondrial fractions [44] . Finally, those same authors demonstrated that mitochondrial fractions from adult heart mitochondria synthesize in vitro some radioactive CL from [14C]PG and [3H]CDP-DG [45] . However, the above studies could not indicate if CL was synthesized from newly synthesized or pre-existing PA. The present study demonstrates unequivocally that new CL may be actively synthesized in the isolated perfused intact rat heart via the Kennedy pathway from newly synthesized PA.
In summary, we have utilized a model, the isolated perfused intact rat heart, for the study of CL biosynthesis. We demonstrated that new CL is actively synthesized from newly synthesized PA via the Kennedy pathway. In addition, we have shown that the rate-limiting step of CL biosynthesis in the isolated perfused intact rat heart is probably the conversion of PA into CDP-DG. 
